• BPC-157 – 10mg

• TB-500 (Thymosin Beta-4 fragment) – 10mg

This dual-peptide blend is designed for research environments exploring connective tissue dynamics, cellular migration pathways, and regeneration signalling models.

Research Focus Areas

In laboratory and preclinical research settings, the individual components of Wolverine have been investigated for their involvement in:

• Tissue repair and regeneration signalling pathways

• Collagen and extracellular matrix research

• Angiogenesis and vascular response models

• Cytoskeletal organisation and cellular migration studies

• Inflammatory pathway modulation research

By combining both peptides in a single vial, researchers can explore complementary pathway interactions within controlled study models.

These findings relate to research contexts only and do not imply therapeutic or approved medical use.

Product Details

• Total Peptide Content: 20mg per vial

  • BPC-157 – 10mg

  • TB-500 – 10mg

• Form: Lyophilised powder

• Purity: ≥ 99% (HPLC verified where applicable)

• Verification: Certificate of Analysis (COA) provided

• Grade: Research use only

Storage & Handling

• Store at 2–8°C or as specified on the COA

• Protect from light and moisture

• Avoid repeated freeze–thaw cycles

• Handle using appropriate laboratory safety and aseptic procedures

Important Notice

This product is supplied strictly for laboratory research purposes.
Not for human or veterinary use.
Not intended to diagnose, treat, cure, or prevent any disease.

The post WOLVERINE – BPC-157 + TB-500 (20mg) appeared first on Pure Peptides Australia.